0000899243-23-011197.txt : 20230412
0000899243-23-011197.hdr.sgml : 20230412
20230412164845
ACCESSION NUMBER: 0000899243-23-011197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230411
FILED AS OF DATE: 20230412
DATE AS OF CHANGE: 20230412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allen Robert D. III
CENTRAL INDEX KEY: 0001972424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 23816191
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invivyd, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 819-0080
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Adagio Therapeutics, Inc.
DATE OF NAME CHANGE: 20201112
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-11
0
0001832038
Invivyd, Inc.
IVVD
0001972424
Allen Robert D. III
C/O INVIVYD, INC.
1601 TRAPELO ROAD, SUITE 178
WALTHAM
MA
02451
0
1
0
0
Chief Scientific Officer
0
Stock Option (Right to Buy)
1.205
2023-04-11
4
A
0
600000
0.00
A
2033-04-10
Common Stock
600000
600000
D
This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of April 11, 2023 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen attorney-in-fact for Robert D. Allen III
2023-04-12